CHECKMATE PHARMACEUTICALS IN's ticker is CMPI and the CUSIP is 162818108. A total of 26 filers reported holding CHECKMATE PHARMACEUTICALS IN in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $3,629,000 | -3.2% | 1,137,764 | -12.9% | 0.28% | +9.6% |
| Q4 2021 | $3,750,000 | -39.7% | 1,306,626 | -16.6% | 0.25% | -33.4% |
| Q3 2021 | $6,222,000 | -33.4% | 1,567,326 | 0.0% | 0.38% | -25.8% |
| Q2 2021 | $9,341,000 | -43.1% | 1,567,326 | +15.9% | 0.51% | -30.7% |
| Q1 2021 | $16,417,000 | -15.2% | 1,352,313 | +1.5% | 0.73% | -46.7% |
| Q4 2020 | $19,353,000 | +30.2% | 1,332,397 | +1.5% | 1.38% | +28.7% |
| Q3 2020 | $14,864,000 | – | 1,313,286 | – | 1.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|